Clinical trial Recruiting at 2 sites Interventional Ages 65 and up

Comparing total and reverse shoulder arthroplasty for shoulder osteoarthritis in older adults

Official title: Study Evaluating Reverse Versus Anatomic Shoulder Arthroplasty Techniques in the Treatment of Osteoarthritis: Protocol

Run by Ottawa Hospital Research Institute · NCT04228419 · Data updated 2026-11-12

This study is testing whether total shoulder surgery or reverse shoulder surgery works better for older adults with shoulder arthritis who haven't found relief from other treatments.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment108 (estimated)
SponsorOttawa Hospital Research Institute
Academic / other
Locations4 sites (Edmonton, Alberta and 3 other locations)
StatusRecruiting
StartedMarch 9, 2020
Main results expectedJanuary 1, 2030
Study endsDecember 31, 2032
Registry record updatedMarch 25, 2025
Trial IDNCT04228419 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients aged 65 and older who have failed non-surgical management for their shoulder osteoarthritis and have specific anatomical criteria.

Probably not a fit

Patients with active joint infections, significant muscle paralysis, or major medical illnesses may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare total shoulder arthroplasty (TSA) and reverse shoulder arthroplasty (RSA) procedures in patients aged 65 and older with glenohumeral osteoarthritis. The study will involve a prospective, randomized-controlled design to assess which surgical approach provides better outcomes for patients with specific anatomical considerations, such as glenoid retroversion. By evaluating the effectiveness and safety of these two surgical options, the research seeks to provide valuable insights for surgeons treating this aging population. The trial will include patients who have not responded to standard non-surgical management for their shoulder condition.

Why it matters

Potential benefit: If successful, this study could help identify the most effective surgical treatment for older patients suffering from shoulder osteoarthritis, potentially improving their quality of life.

How similar studies have gone: While few studies have directly compared TSA and RSA in this specific older population, existing literature suggests that RSA has shown promising outcomes in similar cases, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients who have failed standard non-surgical management of their idiopathic shoulder osteoarthritis who would benefit from a shoulder arthroplasty. Failed medical management will be defined as persistent pain and disability despite adequate standard non-operative management for 6 months. Medical management will be defined as:

   1. The use of drugs including analgesics and non-steroidal anti-inflammatory drugs
   2. Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.)
   3. Activity modification
2. Imaging, and intra-operative findings confirming advanced glenohumeral cartilage loss
3. Patients may present with a glenoid deficiency and \</=15 degrees of retroversion
4. 65 years of age and older

Exclusion Criteria:

1. Active joint or systemic infection
2. Rotator cuff arthropathy
3. Significant muscle paralysis
4. Charcot's arthropathy
5. Major medical illness (life expectancy less than 1 year or unacceptably high operative risk)
6. Unable to understand the consent form/process
7. Pregnancy
8. Psychiatric illness that precludes informed consent
9. Unwilling to be followed for the duration of the study
10. Retroversion cannot be surgically corrected to within 10 degrees of neutral
11. History of previous shoulder surgery on affected side

Where it's running

  • Kingston General Hospital (Site-Watkins 3)
    Kingston, Ontario, Canada
    Recruiting
  • The Ottawa Hospital
    Ottawa, Ontario, Canada
    Recruiting
  • University of Alberta
    Edmonton, Alberta, Canada
    Not yet recruiting
  • Pan Am Clinic Foundation
    Winnipeg, Manitoba, Canada
    Not yet recruiting

Study contacts

  • Principal investigator: Peter Lapner, MD — The Ottawa Hospital
  • Study coordinator: Peter Lapner Lapner, MD
  • Email: plapner@toh.ca
  • Phone: 613-737-8899

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.